Results 31 to 40 of about 19,567,220 (299)
Image_2_Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.tif [PDF]
, 2021 T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792) +9 more
core +1 more source
Asymptotic vectors of entire curves
Математичні Студії, 2021 We introduce a concept of asymptotic vector of an entire curve with linearly independent components and without common zeros and investigate a relationship between the asymptotic vectors and the Picard exceptional vectors. A non-zero vector $\vec{a}=(
Ya.I. Savchuk, A.I. Bandura
doaj +1 more source
Image_3_Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.tif [PDF]
, 2021 T-VEC, a HSV-1 derived oncolytic virus, is approved for the treatment of advanced melanoma. The mechanisms that underly the systemic anti-tumor effect that is seen following intratumoral injection have not yet been studied but are likely to be mediated ...
Inès Dufait (5813792) +9 more
core +1 more source
Melanoma Management, 2020 Aim: Talimogene laherparepvec (T-VEC) is an intralesional therapy for unresectable, metastatic melanoma. T-VEC real-world use in the context of anti-PD1-based therapy requires further characterization. Materials & methods: A retrospective review of T-VEC
James Sun +13 more
doaj +1 more source
Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis
Virology Journal, 2021 Background Oncolytic viruses (OVs) have shown prospects in advanced and metastatic cancer, and many clinical trials have been carried out. To compare OV therapies comprehensively and provide a categorized profile and ranking of efficacy and safety, a ...
Ruiyang Xie +5 more
doaj +1 more source
T-VEC: a tool for developing critical systems [PDF]
Proceedings of 11th Annual Conference on Computer Assurance. COMPASS '96, 2002 This paper describes the specification-based testing and analysis tools, and associated processes, that were used to develop and certify safety-critical avionics systems in an industrial organization. These tools comprise an integrated development environment supporting specification acquisition and analysis, requirement-based automatic test vector ...
M.R. Blackburn, R.D. Busser
openaire +1 more source
Case Reports in Dermatology, 2023 A 66-year-old female with a history of two renal transplants due to recurrent thrombotic thrombocytopenic purpura presented to clinic with multiple lesions identified to be non-metastatic cutaneous squamous cell carcinoma (CSCC).
Max Miller +3 more
doaj +1 more source
The nonnegative weak solution of a degenerate parabolic equation with variable exponent growth order
Boundary Value Problems, 2020 A degenerate parabolic equation of the form ( | v | β − 1 v ) t = div ( b ( x , t ) | ∇ v | p ( x , t ) − 2 ∇ v ) + ∇ g → ⋅ ∇ γ → ( v ) $$\bigl( \vert v \vert ^{\beta-1}v\bigr)_{t}= \operatorname{div} \bigl(b(x,t) \vert \nabla v \vert ^{p(x,t)-2}\nabla v
Huashui Zhan
doaj +1 more source
EBioMedicine, 2019 Background: Talimogene laherparepvec (T-VEC) is an intralesionally delivered, modified herpes simplex virus type-1 oncolytic immunotherapy. The biodistribution, shedding, and potential transmission of T-VEC was systematically evaluated during and after ...
Robert H.I. Andtbacka +9 more
doaj +1 more source
Immunotherapy-Induced Glomerulonephritis: Whodunit?
Graduate Medical Education Research Journal, 2023 Mentor: Ketki Tendulkar Program: Nephrology Type: Case Report Background: Kidney immune-related adverse events are well recognized side effects of immune checkpoint inhibitor therapy.
Brian Benes +4 more
doaj +1 more source